What is Crinetics Pharmaceuticals's stock held in trust?

Crinetics Pharmaceuticals (CRNX) reported stock held in trust of $920K in Q1 2026.

What does stock held in trust mean?

Represents the value of company equity shares held in a trust arrangement, typically for the purpose of funding future employee benefit obligations or deferred compensation plans. This metric reflects the portion of authorized capital that is restricted from immediate market circulation. Monitoring this helps investors understand potential future dilution or the company's strategy for managing long-term equity-based compensation liabilities.

Crinetics Pharmaceuticals CRNX Stock held in trust

Stock held in trust at other companies

TRN

Terreno RealtyTRNO

$36.55M+10.0%

Independent Bank CorpINDB

$3.62M+2.8%

CHE

ChemedCHE

$54.65K-0.8%

First BancorpFBNC

$893K-23.4%

Jones Lang LaSalleJLL

$13.9M+14.9%

EquifaxEFX

$5.9M0.0%

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.79B+21.9%

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept crnx:StockHeldInTrust.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's stock held in trust.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's stock held in trust?: Crinetics Pharmaceuticals (CRNX) reported stock held in trust of $920K in Q1 2026.
What does stock held in trust mean?: Represents the value of company equity shares held in a trust arrangement, typically for the purpose of funding future employee benefit obligations or deferred compensation plans. This metric reflects the portion of authorized capital that is restricted from immediate market circulation. Monitoring this helps investors understand potential future dilution or the company's strategy for managing long-term equity-based compensation liabilities.